Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...

In a recent study, precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS ...

Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...

Global demand for anatomic pathology is accelerating, driven by clinical complexity, molecular integration, AI adoption, ...

Among 117 patients with EGFR-mutated NSCLC who had tried a median ... blinded central review among 80 patients who met a high MET expression criterion. The median duration of response was 7.1 ...

The European Commission on Friday approved AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKNY) Enhertu (trastuzumab ...

Results showed that FGFR2 gene deletion led to significantly fewer precancerous lesions and delayed PDAC tumor formation ...

Notably, FGFR2 expression in murine precancerous lesions ... In addition, the combined inhibition of FGFR2 and another signaling protein, EGFR, significantly reduced the formation of precancerous ...

A landmark migraine study presented at AAN 2025 identified 778 new genetic variants linked to migraine across ancestries in ...

This means cancer cells lacking the gene’s expression are susceptible to tyrosine kinase inhibitors affecting the EGFR, pointing to new possibilities for targeted therapy, it said. DUSP22 expression ...